In this study, we show that PRMT3-mediated R248 methylation of GAPDH is critical for metabolic reprogramming and cellular proliferation, and double blockade of glycolysis and mitochondrial respiration could be a novel strategy for the treatment of PRMT3-overexpressing pancreatic cancer. The gene discussed is GAPDH; the disease is familial pancreatic carcinoma.